Jasper Therapeutics, Inc (JSPR) insider trading
Every open-market stock purchase and sale by Jasper Therapeutics, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- No open-market insider trades in the last 12 months.
- Last insider buy: Patrick J Crutcher (Director), n/a, 3 months ago.
Last 12 months: insiders bought $0 (2 buys) and sold $0 (0 sales). Last close $0.50 on Oct 21, 2026.
Recent JSPR insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Jul 31, 2026 | Thomas G Wiggans (Director) | Bought (not open market) | — |
| Jul 31, 2026 | Svetlana Lucas (Director) | Bought (not open market) | — |
| Jul 31, 2026 | Patrick J Crutcher (Director) | Bought (not open market) | — |
| Jul 31, 2026 | Kurt Von Emster (Director) | Bought (not open market) | — |
| Jul 31, 2026 | Judith Anne Shizuru (Director) | Bought (not open market) | — |
| Jul 20, 2026 | Patrick J Crutcher (Director) | Bought | — |
| Jul 20, 2026 | Matthew E Ros (COO) | Bought | — |
| Jul 16, 2026 | Patrick J Crutcher (Director) | Bought (not open market) | — |
| Feb 6, 2026 | Jeetinder Singh Mahal (CEO) | Bought (not open market) | — |
| Jan 2, 2026 | Herb Cross (CFO) | Bought (not open market) | — |
| Jan 2, 2026 | Ron Martell (CEO) | Bought (not open market) | — |
| Jan 2, 2026 | Jeetinder Singh Mahal (COO) | Bought (not open market) | — |
Who's trading JSPR
- Patrick J Crutcher, Director: bought $0 (1 buy), last Jul 31, 2026
- Kurt Von Emster, Director: other filings, last Jul 31, 2026
- Judith Anne Shizuru, Director: other filings, last Jul 31, 2026
- Thomas G Wiggans, Director: other filings, last Jul 31, 2026
- Svetlana Lucas, Director: other filings, last Jul 31, 2026
- Matthew E Ros, COO: bought $0 (1 buy), last Jul 20, 2026
- Jeetinder Singh Mahal, COO: other filings, last Feb 6, 2026
- Ron Martell, CEO: other filings, last Jan 2, 2026
- Herb Cross, CFO: other filings, last Jan 2, 2026
Get free alerts when an insider at Jasper Therapeutics, Inc files a new trade →